ETHYL 3-IODO-4-METHYL-1H-PYRAZOLE-5-CARBOXYLATE, 95.0%, 250mg

2-Bromo-1-(naphthalen-1-yl)ethanone, 95.0%, 1g

(3-Chloropyridin-2-yl)methanol, 95.0%, 5g

2-Acetamido-5-nitropyridine>98.0%(GC)5g

Infinity corrected plan PL-M 5x/0.14 IOS objective. Working distance 20.5 mm

1-Hydroxy-3,6,9,12,15,18,21-heptaoxatetracosan-24-oic acid, 95%, 500mg

2-Chloro-4-(pyrrolidin-1-yl)benzoic acid, 95.0%, 1g

D-Norvaline, 99.0%, 100g

(R)-1-(2-Fluoro-3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 98%, 100mg

2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)1g

(E)-(3-(3-Ethoxy-3-oxoprop-1-en-1-yl)phenyl)boronic acid, 95.0%, 10g

Benzo[b]thiophen-3(2H)-one 1,1-dioxide, 95.0%, 1g

1-Methoxybutan-2-one, 95%, 1g